Elevation Point Wealth Partners LLC increased its position in shares of Relx Plc (NYSE:RELX – Free Report) by 711.6% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 42,132 shares of the technology company’s stock after buying an additional 36,941 shares during the period. Elevation Point Wealth Partners LLC’s holdings in Relx were worth $1,397,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Annis Gardner Whiting Capital Advisors LLC acquired a new position in Relx during the 4th quarter worth $26,000. Cornerstone Planning Group LLC grew its position in shares of Relx by 2,574.1% in the fourth quarter. Cornerstone Planning Group LLC now owns 722 shares of the technology company’s stock valued at $27,000 after purchasing an additional 695 shares during the last quarter. Transamerica Financial Advisors LLC grew its position in shares of Relx by 3,040.0% in the fourth quarter. Transamerica Financial Advisors LLC now owns 785 shares of the technology company’s stock valued at $32,000 after purchasing an additional 760 shares during the last quarter. Manchester Capital Management LLC increased its stake in shares of Relx by 1,823.6% in the fourth quarter. Manchester Capital Management LLC now owns 1,058 shares of the technology company’s stock worth $43,000 after purchasing an additional 1,003 shares during the period. Finally, Palladiem LLC bought a new position in shares of Relx in the fourth quarter worth about $44,000. 15.02% of the stock is currently owned by institutional investors and hedge funds.
Relx Trading Down 0.0%
Relx stock opened at $31.93 on Monday. The business has a 50 day moving average price of $33.31 and a two-hundred day moving average price of $35.00. The company has a quick ratio of 0.44, a current ratio of 0.49 and a debt-to-equity ratio of 2.38. Relx Plc has a 12 month low of $27.57 and a 12 month high of $54.30.
Analysts Set New Price Targets
Check Out Our Latest Analysis on Relx
Relx Profile
RELX plc is a global provider of information, analytics and decision tools for professional and business customers. The company supplies content, data and analytical services that support decision-making across scientific, technical and medical research, legal and regulatory practice, and risk and business analytics. RELX’s offerings are largely delivered via digital platforms and subscription services designed for institutions, corporations and professionals who require specialized, high-value information and workflow solutions.
RELX operates through distinct business lines that include Elsevier, which provides scientific, technical and medical journals, books and online platforms such as research and discovery tools; Legal and Professional services, which deliver legal, regulatory and compliance content and workflow solutions; Risk & Business Analytics, which offers data, analytics and decision tools for insurance, banking, corporate and government risk assessment; and Exhibitions, which organizes industry trade shows and events.
Read More
- Five stocks we like better than Relx
- Visa’s Open USD Push Puts Circle’s Stablecoin Moat Under Pressure
- This Under-the-Radar Industrial Is Quietly Powering AI
- Why Microsoft Looks Like the Best Big Tech Trade for H2 2026
- Strategy’s Bitcoin Pivot Gives Investors a New Reason to Watch Preferred Shares
Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx Plc (NYSE:RELX – Free Report).
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.
